Ascendis Pharma A/S Issued Capital
Ascendis Pharma A/S (ASND) had Issued Capital of EUR 8.32 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:IssuedCapital · last filed 2026-02-11
- 2025-12-31: Issued Capital 8.32M EUR.
- 2025-09-30: Issued Capital 8.28M EUR.
- 2025-06-30: Issued Capital 8.21M EUR.
- 2025-03-31: Issued Capital 8.19M EUR.
| Period end | Issued Capital |
|---|---|
| 2025-12-31 | 8.32M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | 8.28M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | 8.21M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | 8.19M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | 8.15M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | 8.14M EUR 6-K · filed 2024-11-14 |
| 2024-06-30 | 7.82M EUR 6-K · filed 2024-09-03 |
| 2024-03-31 | 7.82M EUR 6-K · filed 2024-05-02 |
| 2023-12-31 | 7.75M EUR 20-F · filed 2025-02-12 |
| 2023-09-30 | 7.74M EUR 6-K · filed 2023-11-07 |
| 2023-06-30 | 7.70M EUR 6-K · filed 2023-09-05 |
| 2023-03-31 | 7.70M EUR 6-K · filed 2023-04-27 |
| 2023-01-01 | 7.67M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 7.67M EUR 20-F · filed 2024-02-07 |
| 2022-09-30 | 7.66M EUR 6-K · filed 2022-11-02 |
| 2022-06-30 | 7.65M EUR 6-K · filed 2022-08-10 |
| 2022-03-31 | 7.65M EUR 6-K · filed 2022-05-11 |
| 2021-12-31 | 7.65M EUR 20-F · filed 2023-02-16 |
| 2021-09-30 | 7.64M EUR 6-K · filed 2021-11-10 |
| 2021-06-30 | 7.24M EUR 6-K · filed 2021-08-27 |
| 2021-03-31 | 7.23M EUR 6-K · filed 2021-05-27 |
| 2020-12-31 | 7.22M EUR 20-F · filed 2022-03-02 |
| 2020-09-30 | 7.17M EUR 6-K · filed 2020-11-12 |
| 2020-06-30 | 6.49M EUR 6-K · filed 2020-08-27 |
| 2020-03-31 | 6.44M EUR 6-K · filed 2020-05-19 |
| 2019-12-31 | 6.44M EUR 20-F · filed 2021-03-10 |
| 2019-09-30 | 6.41M EUR 6-K · filed 2019-11-18 |
| 2019-06-30 | 6.38M EUR 6-K · filed 2019-08-28 |
| 2019-03-31 | 6.30M EUR 6-K · filed 2019-05-30 |
| 2018-12-31 | 5.66M EUR 20-F · filed 2020-04-03 |
| 2018-09-30 | 5.64M EUR 6-K · filed 2018-11-28 |
| 2018-06-30 | 5.62M EUR 6-K · filed 2018-08-29 |
| 2018-03-31 | 5.58M EUR 6-K · filed 2018-05-30 |
| 2017-12-31 | 4.97M EUR 20-F · filed 2019-04-03 |
| 2016-12-31 | 4.35M EUR 20-F · filed 2018-03-28 |